Gsk Plc ADR (GSK)

$41.48 +0.98 (2.42%)
Market Cap 82.49B
Revenue (ttm) 40.10B
Net Income (ttm) 3.29B
EPS (ttm) N/A
PE Ratio 9.66
Forward PE 9.29
Profit Margin 8.21%
Debt to Equity Ratio 1.21
Volume 2,653,400
Avg Vol 4,663,382
Day's Range N/A - N/A
Shares Out 2.04B
Stochastic %K 98%
Beta 0.53
Analysts Hold
Price Target $39.39

Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephr...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 44 20 8047 5000
Website: www.gsk.com
Address:
79 New Oxford Street, London, United Kingdom
look2theblue
look2theblue Sep. 11 at 1:33 PM
$ITRM With the vote behind us, the team will likely be forced to sell the company. The question is how much and to whom? I think $2-2.50 is best case at this point. And either to $PFE $GSK or $INVA Still a respectable return, but not the $5 most expected.
3 · Reply
DonCorleone77
DonCorleone77 Sep. 9 at 11:13 PM
$AZN $GSK $NVS $RHHBY $BMY President Trump signed a memorandum mandating that pharmaceutical advertisements increase the amount of information regarding risks of the drug in question.
0 · Reply
look2theblue
look2theblue Sep. 9 at 2:15 AM
$ITRM Innoviva is moving personnel into place, Eversana is facilitating. $PFE is watching cautiously from the sidelines with $GSK.
0 · Reply
taxplanr
taxplanr Sep. 9 at 1:55 AM
Are you ready for the pig pHarma advertising change? $ABBV $PFE $MRK $GSK https://sharylattkisson.substack.com/p/fda-commissioner-makary-announces?r=nppkh&amp%3Butm_campaign=post&amp%3Butm_medium=web&amp%3BshowWelcomeOnShare=true&triedRedirect=true
0 · Reply
Judykay
Judykay Sep. 9 at 12:57 AM
$GSK I don't know, maybe come over and look at $KODK Kodak Pharmaceuticals
0 · Reply
Judykay
Judykay Sep. 9 at 12:56 AM
$GSK Hmmm $KODK come check out Kodak Pharmaceuticals. Why don't you look at their specialty chemical profile pdf 2022 and what each one makes.
0 · Reply
taxplanr
taxplanr Sep. 8 at 6:41 PM
This doctor is using Methylene Blue with Ivermectin and Fenbendazole $BNTX $MRNA $ABBV $GSK https://www.instagram.com/reel/DMVU2OOxB9k/?igsh=MWU3enFiN3J6bmlucg==
1 · Reply
AlertsAndNews
AlertsAndNews Sep. 5 at 5:49 PM
$GSK $PFE $JNJ $LLY RFK Jr. to link autism to Tylenol use, folate deficiency- WSJ Reporting this HHS Sec. Robert F. Kennedy Jr. says his upcoming report will cite Tylenol use during pregnancy and low folate levels as potential autism triggers. He also plans to highlight folinic acid (leucovorin) as a treatment for symptoms. Kennedy: “We’re finding interventions now that are clearly, almost certainly causing autism.” CDC data shows 1 in 31 U.S. children diagnosed with autism by age
0 · Reply
AlertsAndNews
AlertsAndNews Sep. 4 at 2:55 PM
$GSK $PFE $MRNA U.S. HEALTH SECRETARY KENNEDY ON CDC VACCINE PANEL: DO NOT ANTICIPATE A CHANGE IN THE MMR VACCINE
1 · Reply
CAN_2409
CAN_2409 Sep. 3 at 8:07 PM
$GSK has the power help small companies with very good Cancer Survival data...
0 · Reply
Latest News on GSK
US tariffs, pricing risks to be manageable for Big Pharma, Morningstar says

Sep 10, 2025, 1:03 PM EDT - 1 day ago

US tariffs, pricing risks to be manageable for Big Pharma, Morningstar says

ABBV AZN NVO NVS SNY AMGN LLY

Why Is GSK Partner Wave Life Sciences Stock Trading Lower On Wednesday?

Sep 3, 2025, 1:28 PM EDT - 8 days ago

Why Is GSK Partner Wave Life Sciences Stock Trading Lower On Wednesday?

WVE

Dynavax's shingles vaccine shows similar immune response to GSK's shot in study

Aug 21, 2025, 8:22 AM EDT - 21 days ago

Dynavax's shingles vaccine shows similar immune response to GSK's shot in study

DVAX

GSK's antibiotic drug gepotidacin gets priority review by FDA

Aug 11, 2025, 2:15 AM EDT - 4 weeks ago

GSK's antibiotic drug gepotidacin gets priority review by FDA

GSK to Receive $370 Million in U.S. Patent Litigation Settlement

Aug 8, 2025, 3:31 AM EDT - 5 weeks ago

GSK to Receive $370 Million in U.S. Patent Litigation Settlement

Pharmaceutical makers were largely unshaken by new demands from President Trump to lower drug prices, with experts saying the measures would either have modes impact or face legal challenges

Aug 1, 2025, 12:01 PM EDT - 5 weeks ago

Pharmaceutical makers were largely unshaken by new demands from President Trump to lower drug prices, with experts saying the measures would either have modes impact or face legal challenges

ABBV AMGN AZN BMY GILD JNJ LLY

Pharma Companies Should Immediately Cut Down Drug Prices, Trump Says

Jul 31, 2025, 3:35 PM EDT - 6 weeks ago

Pharma Companies Should Immediately Cut Down Drug Prices, Trump Says

ABBV AMGN AZN BMY GILD JNJ LLY

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days.

Jul 31, 2025, 3:00 PM EDT - 6 weeks ago

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days.

ABBV AMGN AZN BMY GILD JNJ LLY

Trump pressures 17 pharma CEOs to cut US drug prices

Jul 31, 2025, 2:28 PM EDT - 6 weeks ago

Trump pressures 17 pharma CEOs to cut US drug prices

ABBV AMGN AZN BMY GILD JNJ LLY

Trump posts letters to 17 pharmaceutical companies about drug prices

Jul 31, 2025, 2:19 PM EDT - 6 weeks ago

Trump posts letters to 17 pharmaceutical companies about drug prices

ABBV GILD LLY PFE AMGN AZN BMY

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days

Jul 31, 2025, 1:48 PM EDT - 6 weeks ago

Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days

ABBV AMGN AZN BMY GILD JNJ LLY

GSK plc (GSK) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 5:56 PM EDT - 6 weeks ago

GSK plc (GSK) Q2 2025 Earnings Call Transcript

GSK CEO: Innovation is the secret to bringing down cost of overall healthcare

Jul 30, 2025, 11:32 AM EDT - 6 weeks ago

GSK CEO: Innovation is the secret to bringing down cost of overall healthcare

GSK in talks with Trump administration on U.S. drug pricing, CEO says

Jul 30, 2025, 5:26 AM EDT - 6 weeks ago

GSK in talks with Trump administration on U.S. drug pricing, CEO says

GSK expects annual sales and profit at top end of forecast range

Jul 30, 2025, 2:12 AM EDT - 6 weeks ago

GSK expects annual sales and profit at top end of forecast range

GSK: I Foresee Only Very Modest Upside Here Even If Blenrep Gets FDA Approval

Jul 28, 2025, 12:41 PM EDT - 6 weeks ago

GSK: I Foresee Only Very Modest Upside Here Even If Blenrep Gets FDA Approval

Jiangsu Hengrui grants GSK global rights to drug portfolio in $500 million deal

Jul 27, 2025, 10:35 PM EDT - 6 weeks ago

Jiangsu Hengrui grants GSK global rights to drug portfolio in $500 million deal

Hengrui Pharma and GSK enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

Jul 27, 2025, 9:53 PM EDT - 6 weeks ago

Hengrui Pharma and GSK enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

GSK's blood cancer drug gets EU approval for multiple myeloma

Jul 24, 2025, 12:27 PM EDT - 7 weeks ago

GSK's blood cancer drug gets EU approval for multiple myeloma

GSK sponsors 2025 National Senior Games as part of Sideline RSV campaign to raise awareness of RSV in older adults

Jul 24, 2025, 9:00 AM EDT - 7 weeks ago

GSK sponsors 2025 National Senior Games as part of Sideline RSV campaign to raise awareness of RSV in older adults

US FDA extends review of GSK's blood cancer drug

Jul 23, 2025, 12:15 PM EDT - 7 weeks ago

US FDA extends review of GSK's blood cancer drug

GSK Shares Drop After FDA Committee Vote Leaves Cancer-Drug Comeback in Doubt

Jul 18, 2025, 8:44 AM EDT - 7 weeks ago

GSK Shares Drop After FDA Committee Vote Leaves Cancer-Drug Comeback in Doubt

GSK shares fall after blood cancer drug likely headed for U.S. rejection

Jul 18, 2025, 3:24 AM EDT - 2 months ago

GSK shares fall after blood cancer drug likely headed for U.S. rejection

FDA Committee Votes Against GSK Blood Cancer Drug Blenrep

Jul 17, 2025, 6:19 PM EDT - 2 months ago

FDA Committee Votes Against GSK Blood Cancer Drug Blenrep

GSK's Linerixibat Poised to Address Substantial Unmet Need for the Treatment of Pruritus Associated with Primary Biliary Cholangitis, According to Spherix Global Insights

Jul 17, 2025, 1:00 PM EDT - 2 months ago

GSK's Linerixibat Poised to Address Substantial Unmet Need for the Treatment of Pruritus Associated with Primary Biliary Cholangitis, According to Spherix Global Insights

FDA advisers vote against combination therapies of GSK's blood cancer drug

Jul 17, 2025, 12:53 PM EDT - 2 months ago

FDA advisers vote against combination therapies of GSK's blood cancer drug

US FDA approves pre-filled version of GSK's shingles vaccine

Jul 17, 2025, 7:35 AM EDT - 2 months ago

US FDA approves pre-filled version of GSK's shingles vaccine

US FDA Approves GSK's SHINGRIX in a Prefilled Syringe Presentation

Jul 17, 2025, 7:00 AM EDT - 2 months ago

US FDA Approves GSK's SHINGRIX in a Prefilled Syringe Presentation

FDA staff raises eye damage concerns for GSK's blood cancer drug

Jul 15, 2025, 8:51 AM EDT - 2 months ago

FDA staff raises eye damage concerns for GSK's blood cancer drug

GSK seeks FDA nod for expanded use of RSV vaccine in adults

Jul 14, 2025, 2:42 AM EDT - 2 months ago

GSK seeks FDA nod for expanded use of RSV vaccine in adults

GSK begins shipping influenza vaccine doses for the 2025-26 flu season

Jul 10, 2025, 9:13 AM EDT - 2 months ago

GSK begins shipping influenza vaccine doses for the 2025-26 flu season

GSK's Specialty Medicines Surge - Still Looks Undervalued In 2025

Jul 7, 2025, 7:45 AM EDT - 2 months ago

GSK's Specialty Medicines Surge - Still Looks Undervalued In 2025

US Senator investigates GSK for pulling children's asthma inhaler

Jun 27, 2025, 9:11 AM EDT - 2 months ago

US Senator investigates GSK for pulling children's asthma inhaler

Bharat, GSK to halve price of malaria vaccine by 2028

Jun 25, 2025, 3:29 AM EDT - 2 months ago

Bharat, GSK to halve price of malaria vaccine by 2028

FDA approves Benlysta (belimumab) Autoinjector for children with active lupus nephritis

Jun 24, 2025, 9:00 AM EDT - 2 months ago

FDA approves Benlysta (belimumab) Autoinjector for children with active lupus nephritis

GSK announces the Linked by Lupus: Optimal Care Initiative to help support individuals with lupus in the US

Jun 16, 2025, 9:33 AM EDT - 3 months ago

GSK announces the Linked by Lupus: Optimal Care Initiative to help support individuals with lupus in the US

GSK says EU heath regulator reviewing expansion of RSV vaccine

Jun 13, 2025, 2:14 AM EDT - 3 months ago

GSK says EU heath regulator reviewing expansion of RSV vaccine

Theravance Biopharma, Inc. Sells Remaining Royalty Interest in Trelegy Ellipta to GSK for $225 Million

Jun 2, 2025, 6:00 AM EDT - 3 months ago

Theravance Biopharma, Inc. Sells Remaining Royalty Interest in Trelegy Ellipta to GSK for $225 Million

TBPH

Carat Group's Fred Hassan dives into what pharma companies to watch at 2025 ASCO Annual Meeting

May 30, 2025, 12:23 PM EDT - 3 months ago

Carat Group's Fred Hassan dives into what pharma companies to watch at 2025 ASCO Annual Meeting

AMGN MRK PFE

Why Is GSK Partner Spero Therapeutics Stock Skyrocketing On Wednesday?

May 28, 2025, 11:24 AM EDT - 3 months ago

Why Is GSK Partner Spero Therapeutics Stock Skyrocketing On Wednesday?

SPRO

GSK, Spero to stop urinary tract infection drug trial due to early success

May 28, 2025, 7:18 AM EDT - 3 months ago

GSK, Spero to stop urinary tract infection drug trial due to early success

Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy Following Review by Independent Data Monitoring Committee

May 28, 2025, 7:00 AM EDT - 3 months ago

Spero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy Following Review by Independent Data Monitoring Committee

SPRO

Nucala (mepolizumab) approved by US FDA for use in adults with chronic obstructive pulmonary disease (COPD)

May 22, 2025, 4:15 PM EDT - 4 months ago

Nucala (mepolizumab) approved by US FDA for use in adults with chronic obstructive pulmonary disease (COPD)

GSK's asthma drug Nucala wins FDA's approval to treat 'smoker's lung'

May 22, 2025, 2:13 PM EDT - 4 months ago

GSK's asthma drug Nucala wins FDA's approval to treat 'smoker's lung'

look2theblue
look2theblue Sep. 11 at 1:33 PM
$ITRM With the vote behind us, the team will likely be forced to sell the company. The question is how much and to whom? I think $2-2.50 is best case at this point. And either to $PFE $GSK or $INVA Still a respectable return, but not the $5 most expected.
3 · Reply
DonCorleone77
DonCorleone77 Sep. 9 at 11:13 PM
$AZN $GSK $NVS $RHHBY $BMY President Trump signed a memorandum mandating that pharmaceutical advertisements increase the amount of information regarding risks of the drug in question.
0 · Reply
look2theblue
look2theblue Sep. 9 at 2:15 AM
$ITRM Innoviva is moving personnel into place, Eversana is facilitating. $PFE is watching cautiously from the sidelines with $GSK.
0 · Reply
taxplanr
taxplanr Sep. 9 at 1:55 AM
Are you ready for the pig pHarma advertising change? $ABBV $PFE $MRK $GSK https://sharylattkisson.substack.com/p/fda-commissioner-makary-announces?r=nppkh&amp%3Butm_campaign=post&amp%3Butm_medium=web&amp%3BshowWelcomeOnShare=true&triedRedirect=true
0 · Reply
Judykay
Judykay Sep. 9 at 12:57 AM
$GSK I don't know, maybe come over and look at $KODK Kodak Pharmaceuticals
0 · Reply
Judykay
Judykay Sep. 9 at 12:56 AM
$GSK Hmmm $KODK come check out Kodak Pharmaceuticals. Why don't you look at their specialty chemical profile pdf 2022 and what each one makes.
0 · Reply
taxplanr
taxplanr Sep. 8 at 6:41 PM
This doctor is using Methylene Blue with Ivermectin and Fenbendazole $BNTX $MRNA $ABBV $GSK https://www.instagram.com/reel/DMVU2OOxB9k/?igsh=MWU3enFiN3J6bmlucg==
1 · Reply
AlertsAndNews
AlertsAndNews Sep. 5 at 5:49 PM
$GSK $PFE $JNJ $LLY RFK Jr. to link autism to Tylenol use, folate deficiency- WSJ Reporting this HHS Sec. Robert F. Kennedy Jr. says his upcoming report will cite Tylenol use during pregnancy and low folate levels as potential autism triggers. He also plans to highlight folinic acid (leucovorin) as a treatment for symptoms. Kennedy: “We’re finding interventions now that are clearly, almost certainly causing autism.” CDC data shows 1 in 31 U.S. children diagnosed with autism by age
0 · Reply
AlertsAndNews
AlertsAndNews Sep. 4 at 2:55 PM
$GSK $PFE $MRNA U.S. HEALTH SECRETARY KENNEDY ON CDC VACCINE PANEL: DO NOT ANTICIPATE A CHANGE IN THE MMR VACCINE
1 · Reply
CAN_2409
CAN_2409 Sep. 3 at 8:07 PM
$GSK has the power help small companies with very good Cancer Survival data...
0 · Reply
StocktwitsNews
StocktwitsNews Sep. 3 at 6:57 PM
Wave Life Sciences Tumbled 19% Today, But Not Everyone’s Disappointed – Find Out Why $WVE $GSK $IWMW https://stocktwits.com/news/equity/markets/wave-life-sciences-stock-tumbled-wednesday-after-study-update/chwcIBKRdoB
0 · Reply
Quantumup
Quantumup Sep. 3 at 6:20 PM
Leerink⬆️ $WVE's PT to $26 from $24, reit'd Outperform & said it thinks invs should take advantage of weakness to buy, ahead of add'l important catalysts, which they remain optimistic investors will appreciate. $GSK $ARWR TAK $KRRO SNY NTLA BEAM $LLY NVO VKTX GPCR Raymond James reit'd $WVE Outperform-$14 & said, We continue to view $WVE's wholly-owned gene-editing programs as more likely LT value drivers - sees WVE-007 (INHBE) in obesity (4Q 2025) as the most important near-term stock-moving catalyst, with an attractive risk/ reward skew. Leerink and Raymond James said in their notes to investors:
1 · Reply
look2theblue
look2theblue Sep. 3 at 3:20 AM
$ITRM All this Innoviva speculation with the new hire and $GSK - one could look to $SPRO marketcap post $GSK interest as a reference to see what $ITRM intrinsic value might actually be if $GSK were is looking to acquire Iterum - about $2/share. Factor in any competitive interest from $PFE and it could be a touch higher.
1 · Reply
ZacksResearch
ZacksResearch Sep. 2 at 3:40 PM
$GSK just tacked on $5B in a month — what’s fueling the surge? Specialty Medicines growth, pipeline wins, and a strong outlook are driving momentum, even as vaccine headwinds linger. Full game plan on how to play the stock 👉 https://www.zacks.com/stock/news/2745997/gsk-adds-around-5b-in-a-month-heres-how-to-play-the-stock?cid=sm-stocktwits-2-2745997-teaser-10490&ADID=SYND_STOCKTWITS_TWEET_2_2745997_TEASER_10490
0 · Reply
ZacksResearch
ZacksResearch Sep. 2 at 2:40 PM
$GSK up 6.4% in a month — is there more room to run? 🚀 Strong performance in Specialty Medicines is driving growth, with sales in this unit up 16% in H1 2025. The stock is trading at a bargain P/E of 8.58, well below the pharmaceutical industry's 14.78. Discover why staying invested might pay off 👉 https://www.zacks.com/stock/news/2745997/gsk-adds-around-5b-in-a-month-heres-how-to-play-the-stock?cid=sm-stocktwits-2-2745997-body-10462&ADID=SYND_STOCKTWITS_TWEET_2_2745997_BODY_10462
0 · Reply
BiDirDelta
BiDirDelta Aug. 29 at 11:15 AM
$MRK $GSK $DVAX September Sneak Peek >> What are the Active and Inactive contents (ingredients) contained in the Hepatitis B Vaccines? Millions of Inquiring Minds Want to Know, NOW? The Entire Autism Community Wants to Know, NOW?
0 · Reply
BiDirDelta
BiDirDelta Aug. 29 at 11:05 AM
$MRK $GSK $DVAX The following Will Be BEARISH for big pharma and BULLISH for New Expecting Mothers and Current Autistic Children + Adults The TRUTH Will Set Them All Free RFK Jr. Reveals HHS Has Identified “Interventions” Behind MASSIVE Autism Spike in Children — Full Announcement Coming in September https://www.thegatewaypundit.com/2025/08/rfk-jr-reveals-hhs-has-identified-interventions-behind/
0 · Reply
BiDirDelta
BiDirDelta Aug. 29 at 11:02 AM
$MRK $GSK $DVAX Let me Correct the Media Narrative On The Real Reasons There is Senior Level Employment Volatility at the CDC -- It Will All Come Out in the Wash so to Speak in September = Hint "Autism Origins" >> See my Next Post BREAKING: At Least Three Senior CDC Officials Resign After Dr. Monarez Ousted as CDC Director… Cites “Ongoing Weaponization of Public Health” https://www.thegatewaypundit.com/2025/08/breaking-least-three-senior-cdc-officials-resign-after/
0 · Reply
StocktwitsNews
StocktwitsNews Aug. 28 at 2:10 AM
GSK Secures UK Approval For First New Oral Antibiotic In 30 Years To Treat Resistant Urinary Tract Infections $GSK https://stocktwits.com/news/equity/markets/gsk-secures-uk-approval-for-first-new-oral-antibiotic-in-30-years-to-treat-resistant-urinary-tract-infections/chsCM1iRdl1
0 · Reply
Quantumup
Quantumup Aug. 26 at 8:05 PM
BTIG reit'd $TBPH Buy-$25/said it conts2view CYPRESS as sig derisked by preceding P3s— $TBPH utilized an external enrollment cmte =g same clinical neuro's for both Study 0170/CYPRESS, supporting pot for +VE readthru between the two trials. $ATHE $HLUBF $HLBBF $GSK AZN BTIG said:
0 · Reply
larryr15
larryr15 Aug. 26 at 4:26 PM
Grail, With Some Help, May Hugely Boost Cancer Survival Rates https://finance.yahoo.com/community/post/e5e67735-05bb-4ffb-b3f0-6a5de959058b/ $GRAL $IBRX $GSK $MRK
0 · Reply
Max9090
Max9090 Aug. 26 at 8:24 AM
$BMY $GSK $NVO $PFE
0 · Reply